Dissemination level: Public Heart-e-Gel project: “Microsystem integration based on electroactive polymer gels for cardiovascular applications” Deliverable 6.1: “Adapted pulse duplicator working with hemodynamic profile at intended vascular locations” Responsible Beneficiary: __________________________________________________________________________ FP7-ICT-2009-5 - Small or Medium-scale Focused Research Project STREP: CP-FP-INFSO Heart-e-Gel 258909 ICT-5-3.9 – Microsystems and Smart Miniaturised Systems 1 KU Leuven Due Date: 1st March 2011 Submission Date: 15th April 2011 1 TABLE OF CONTENTS 1 Table of Contents............................................................................................. Error! Bookmark not defined. 3 Introduction .................................................................................................................................................... 4 4 Artificial Circulation System ............................................................................................................................ 4 5 Results ............................................................................................................................................................ 6 6 Conclusion ...................................................................................................................................................... 7 7 Figures ............................................................................................................................................................ 8 8 References .................................................................................................................................................... 17 __________________________________________________________________________ FP7-ICT-2009-5 - Small or Medium-scale Focused Research Project STREP: CP-FP-INFSO Heart-e-Gel 258909 ICT-5-3.9 – Microsystems and Smart Miniaturised Systems 2 __________________________________________________________________________ FP7-ICT-2009-5 - Small or Medium-scale Focused Research Project STREP: CP-FP-INFSO Heart-e-Gel 258909 ICT-5-3.9 – Microsystems and Smart Miniaturised Systems 3 2 INTRODUCTION Several different types of artificial circulation systems have been described in literature, their morphology depends strongly on the study protocol 1 2 3 4 5 6 7 . In vitro circulations have several advantages: a lot of parameters are controllable (pulse rate, pressure, resistance, compliance), the setup is reproducible, large numbers of data can be easily obtained. On the contrary in vitro models are often a balance between reduction in mechanical complexity and accuracy of the investigation. Ideally artificial circulation systems should be capable of producing pulsatile and nonpulsatile flow conditions as these are encountered under physical conditions. For example, in the aorta the flow rate is close to 5000ml/min with a systolic pressure of 120 mm Hg and diastolic pressure of 80 mm Hg, with a duration of the systolic phase of one third of the cardiac cycle and with a frequency of the pulsatility of 60 beats per minute (bpm). On the other hand, in veins there is a continous, low-pressure, nonpulsatile flow. Most of the described systems cannot be easily adapted to produce these variable flow conditions. It should also be possible to do experiments with whole blood as a working fluid, so biocompatible surfaces and low mechanical forces are needed to achieve a low hemolysis index 8 9 . The aim of this deliverable is to produce a mock circulation system that mimics the pressure and flow patterns of the human arterial, venous and ventricular sytem. This system is used to evaluate the hydrogels as they may have a wide range of applications and should be tested under a wide range of flow and pressure conditions. 3 ARTIFICIAL CIRCULATION SYSTEM An in vitro circulation system was build that consists of four elements (figure 1): the pump system, the circulatory system, the test compartment module, and the acquisition and analysis monitoring system. The pump system consists of two elements placed in parallel: a roller pump and a pneumatically driven ventricule. The roller pump (Sarns Inc, Ann Arbor, Michigan, USA) generates a constant flow which can be changed according to the application by __________________________________________________________________________ FP7-ICT-2009-5 - Small or Medium-scale Focused Research Project STREP: CP-FP-INFSO Heart-e-Gel 258909 ICT-5-3.9 – Microsystems and Smart Miniaturised Systems 4 adjusting the rotations per minute (rpm). The second element is a pneumatically driven ventricle of 60 ml (Ventricle Assist Device, Medos, Stolberg, Deutschland). This is used to induce pulsatility within the generated flow. The rate, inflation pressure, suction pressure and relative time of systole are adjustable, allowing measurements under a wide range of hemodynamic consitions. The pulsatile pump system is connected with a reservoir, which is mounted 5 cm above the horizontal plane of the test compartment. In front of the venous reservoir is a heat exchanger (D720A Helios, Sorin Group, Mirandola, Italy) to keep the temperature at a physiologic level (36-38°C). The system can be filled with several solutions: water, a blood analog (a 40% glycerol/water mixture to simulate the viscosity of blood or Krebs Henseleit solution to simulate the composition of blood) or anticoagulated blood. During the experiments the system is filled with 2000 cc of liquid. For maintance of the water quality 2 ml Prothermal (Lucernachem, Luzern, Switzerland) per 1 liter test fluid can be added. After the experiment the fluid is filtered to obtain information about the embolic characteristics with a 0.2 micron filter Pall laboratories (Port Washington, NY, USA). The circulatory system consists of a closed, Windkessel, cylindrical chamber (Plexiglass, height 13 cm, diameter 12 cm), which represents the vessel wall distensibility and a tourniquet that squeezes a tube segment in order to simulate circulatory system peripheral resistence. The compliance chamber is placed between the pump system and the test compartment. A manual inflation system is placed on top of the chamber to modify the volume of compressed air inside the chamber, and so modify the compliance within the artificial circulation. The compliance (C=V/P) of the chamber was calculated measuring the volume (V) of water needed to obtain a pressure increase (P) of 40 mmHg. The compliance was measured in the physiologic pressure range (0 mm Hg – 200 mm Hg) for different amounts of air in the chamber (figure 2). By squeezing a tube segment with a tourniquet, which is placed between the test compartment and the venous reservoir, the internal area is reduced and the circulatory system peripheral resistance is augmented. Both the compliance chamber and circulatory resistance system are used to obtain physiologic wave forms of flow and pressure. __________________________________________________________________________ FP7-ICT-2009-5 - Small or Medium-scale Focused Research Project STREP: CP-FP-INFSO Heart-e-Gel 258909 ICT-5-3.9 – Microsystems and Smart Miniaturised Systems 5 The test compartment module (figure 3) is made of plastic and it is possible to fit different vessel models in. These vessel models are self-made latex vessels or animal vessels obtained from the abbatoir. The different latex vessels models (figure 4) for the test compartment are obtained by repetitively dipping a mould in a silicone rubber latex solution. Each coat is allowed to dry for approximately 30 minutes. When eight layers were obtained the model was immersed in warm water for 1 hour. This soaking pocess aided the model to be removed from the mould. Depending on the study protocol several adjusments and side-branches can be made. The connections between the circulatory system and the different components are made of cardiopulmonary bypass tubing (3/8 and 1/2 inch). The acquisition and analysis monitoring system is composed of a set of transducers. An ultrasonic flow transducer (HT110, Transonic Systems, Ithaca, NY, USA) is placed downstream of the pumps and is used to acquire hydrodynamic information of the mock system. The flow probe is callibrated for the tubing size, the test fluid and the temperature. Pressure transducers (Edwards Lifesciences LLC, Irvine, CA, USA) are placed before and after the test compartment module to investigate the behavior of the simulator. The pressure monitor (HP 78534A Monitor, Hewlett Packard, Loveland, Colorado, USA) is calibrated before each serie of measurements. A temperature transducer is placed in the venous reservoir to keep temperature within physiologic level. To evaluate the influence of hydrogels on the elasticity of the vessel wall, the displacement of the vessel wall can be monitored with a sonomicrometry system (Sonosoft, Sonometrics cooperation, London, Canada). All measured signals were acquired by a data acquisition board (USB-6008, National Instruments, Austin, Texas, USA). The signals are sampled at 1 kHz and low-pass filtered at 10 Hz in orde to acquire a reasonable sampling rate and to remove unwanted signal components. A monitoring program is written in LabView SignalExpress (National Instruments, Austin, Texas, USA). 4 RESULTS __________________________________________________________________________ FP7-ICT-2009-5 - Small or Medium-scale Focused Research Project STREP: CP-FP-INFSO Heart-e-Gel 258909 ICT-5-3.9 – Microsystems and Smart Miniaturised Systems 6 For testing the electroactive hydrogel in different applications, the hemodynamic setting can be modulated to obtain venous or arterial hemodynamic conditions. To obtain venous conditions the pneumatically driven ventricle is switched of, there is a high compliance within the compliance chamber and the resistance is set on a low level. In this way a constant, low pressure flow is generated. To test the occlusion capacity of the electroactive hydrogels within a venous environment, vessel models can be mounted within the test compartment module as given in figure 5. To obtain arterial conditions the settings of the pneumatic ventricle are defined as follows: systolic inflation pressure is 300mm Hg, the diastolic suction pressure -20mm Hg, the heart rate 60 beats per minute, and the duration of the systole is 35% of the cardiac cycle. As given in figure 6, it is possible to obtain arterial pressure and flow curves which resemble the normal arterial curve very well. There is a frequency of 60 bpm, a systolic lenght of approximately one thirth of the cardiac cycle, during diastole there is a rapid decrease in pressure with a slower decline thereafter and the pulse pressure is around 40 mm Hg. The systolic and diastolic pressure can be changed by adjusting the resistance and the compliance. The overal flow can be diminished by reducing the rotation per minute of the roller pump. These settings can be used to test the occlusion of an artery or abnormal arterio-venous connection (figure 7) and the occlusion of an aneurysm sac (figure 8). 5 CONCLUSION This artificial circulation will enable future research of hydrogels. In comparison with other pulse duplicators this system can generate pulsatile and nonpulsatile flow and allows testing of these devices in a broad range of hemodynamic features. As the circulation can be filled with blood or an analog the influences of the blood components on the device can be evaluated as well as the influences of the device on blood. In this way protein, lipid and cellular infiltration within the device can be evaluated. __________________________________________________________________________ FP7-ICT-2009-5 - Small or Medium-scale Focused Research Project STREP: CP-FP-INFSO Heart-e-Gel 258909 ICT-5-3.9 – Microsystems and Smart Miniaturised Systems 7 6 FIGURES __________________________________________________________________________ FP7-ICT-2009-5 - Small or Medium-scale Focused Research Project STREP: CP-FP-INFSO Heart-e-Gel 258909 ICT-5-3.9 – Microsystems and Smart Miniaturised Systems 8 Figure 1: Schematic representation of the artificial circulation (1= roller pump; 2= pneumatically driven ventricle; 3= compliance chamber, 4= test compartment; 5= resistance; 6= heat exchanger; 7= reservoir; F= flow sensor: Pa, Pb= pressure sensor, S= sonomicrometry). __________________________________________________________________________ FP7-ICT-2009-5 - Small or Medium-scale Focused Research Project STREP: CP-FP-INFSO Heart-e-Gel 258909 ICT-5-3.9 – Microsystems and Smart Miniaturised Systems 9 __________________________________________________________________________ FP7-ICT-2009-5 - Small or Medium-scale Focused Research Project STREP: CP-FP-INFSO Heart-e-Gel 258909 ICT-5-3.9 – Microsystems and Smart Miniaturised Systems 10 Figure 2: The compliance in the prerssure function for different amounts of air in the Windkessel. __________________________________________________________________________ FP7-ICT-2009-5 - Small or Medium-scale Focused Research Project STREP: CP-FP-INFSO Heart-e-Gel 258909 ICT-5-3.9 – Microsystems and Smart Miniaturised Systems 11 Figure 3: View on the compliance chamber (A), the test compartment with latex aneurysm model (B), flow sensor (C) and pressure transducers (D). __________________________________________________________________________ FP7-ICT-2009-5 - Small or Medium-scale Focused Research Project STREP: CP-FP-INFSO Heart-e-Gel 258909 ICT-5-3.9 – Microsystems and Smart Miniaturised Systems 12 Figure 4: Examples of different latex vessel models which can be mounted within the test compartment. __________________________________________________________________________ FP7-ICT-2009-5 - Small or Medium-scale Focused Research Project STREP: CP-FP-INFSO Heart-e-Gel 258909 ICT-5-3.9 – Microsystems and Smart Miniaturised Systems 13 Figure 5: Test compartment for testing venous occlusion (1= hydrogel). __________________________________________________________________________ FP7-ICT-2009-5 - Small or Medium-scale Focused Research Project STREP: CP-FP-INFSO Heart-e-Gel 258909 ICT-5-3.9 – Microsystems and Smart Miniaturised Systems 14 Figure 6: An example of arterial pressure and flow curves generated by the pulse duplicator. __________________________________________________________________________ FP7-ICT-2009-5 - Small or Medium-scale Focused Research Project STREP: CP-FP-INFSO Heart-e-Gel 258909 ICT-5-3.9 – Microsystems and Smart Miniaturised Systems 15 Figure 7: Test compartment for testing arterial occlusion / arterio-venous connection (1= hydrogel; 2= resistance; A= high pressure; B= low pressure). __________________________________________________________________________ FP7-ICT-2009-5 - Small or Medium-scale Focused Research Project STREP: CP-FP-INFSO Heart-e-Gel 258909 ICT-5-3.9 – Microsystems and Smart Miniaturised Systems 16 Figure 8: Test compartment for testing aneurysmal sac occlusion (1= hydrogel; 2= endoprosthesis). 7 REFERENCES 1. Donovan FM, Jr. Design of a hydraulic analog of the circulatory system for evaluating artificial hearts. Biomater Med Devices Artif Organs 1975; 3(4):439-49. 2. Vermette P, Thibault J, Laroche G. A continuous and pulsatile flow circulation system for evaluation of cardiovascular devices. Artif Organs 1998; 22(9):746-52. 3. Schima H, Baumgartner H, Spitaler F, et al. A modular mock circulation for hydromechanical studies on valves, stenoses, vascular grafts and cardiac assist devices. Int J Artif Organs 1992; 15(7):417-21. __________________________________________________________________________ FP7-ICT-2009-5 - Small or Medium-scale Focused Research Project STREP: CP-FP-INFSO Heart-e-Gel 258909 ICT-5-3.9 – Microsystems and Smart Miniaturised Systems 17 4. Vandenberghe S, Segers P, Meyns B, Verdonck P. Hydrodynamic characterisation of ventricular assist devices. Int J Artif Organs 2001; 24(7):470-7. 5. Verdonck P, Kleven A, Verhoeven R, et al. Computer-controlled in vitro model of the human left heart. Med Biol Eng Comput 1992; 30(6):656-9. 6. Legendre D, Fonseca J, Andrade A, et al. Mock circulatory system for the evaluation of left ventricular assist devices, endoluminal prostheses, and vascular diseases. Artif Organs 2008; 32(6):461-7. 7. Liu Y, Allaire P, Wood H, Olsen D. Design and initial testing of a mock human circulatory loop for left ventricular assist device performance testing. Artif Organs 2005; 29(4):341-5. 8. Tamari Y, Lee-Sensiba K, Leonard EF, et al. The effects of pressure and flow on hemolysis caused by Bio-Medicus centrifugal pumps and roller pumps. Guidelines for choosing a blood pump. J Thorac Cardiovasc Surg 1993; 106(6):997-1007. 9. Schima H, Muller MR, Tsangaris S, et al. Mechanical blood traumatization by tubing and throttles in in vitro pump tests: experimental results and implications for hemolysis theory. Artif Organs 1993; 17(3):164-70. __________________________________________________________________________ FP7-ICT-2009-5 - Small or Medium-scale Focused Research Project STREP: CP-FP-INFSO Heart-e-Gel 258909 ICT-5-3.9 – Microsystems and Smart Miniaturised Systems 18